Non Hodgkin's Lymphoma News and Research

RSS
The Non-Hodgkin lymphomas (NHLs) are a diverse group of hematologic cancers which encompass any lymphoma other than Hodgkin's Lymphoma.
Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

International collaboration secures €1M grant to investigate new treatment target for lymphoma

International collaboration secures €1M grant to investigate new treatment target for lymphoma

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

MDC researchers develop a potent weapon against lymphomas

MDC researchers develop a potent weapon against lymphomas

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

FDA provides update on adverse events associated with breast implants

FDA provides update on adverse events associated with breast implants

New cancer vaccine shows promising signs in preclinical studies

New cancer vaccine shows promising signs in preclinical studies

People with a cancer history have increased risk of developing atrial fibrillation

People with a cancer history have increased risk of developing atrial fibrillation

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Molecular mechanisms involved in Pixantrone's interactions with cancer DNA discovered

Molecular mechanisms involved in Pixantrone's interactions with cancer DNA discovered

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Patients with non-Hodgkin's lymphoma may benefit from radiation, experience reduced side effects

Patients with non-Hodgkin's lymphoma may benefit from radiation, experience reduced side effects

Chemotherapy can wreak havoc on the heart

Chemotherapy can wreak havoc on the heart

Cancer vaccine injected into tumour could kill all cancer cells

Cancer vaccine injected into tumour could kill all cancer cells

Common herbicide found to increase the risk of Non-Hodgkin Lymphoma

Common herbicide found to increase the risk of Non-Hodgkin Lymphoma